# Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension

> **NCT00675051** · — · COMPLETED · sponsor: **University of California, San Francisco** · enrollment: 20 (actual)

## Conditions studied

- Pulmonary Hypertension

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00675051
- **Lead sponsor:** University of California, San Francisco
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2009-02
- **Final completion:** 2009-02
- **Target enrollment:** 20 (ACTUAL)
- **Last updated:** 2016-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00675051

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00675051, "Effect of Endothelin-1 Receptor Blockade on Circulating Endothelial Microparticles Levels in Patients With Pulmonary Hypertension". Retrieved via AI Analytics 2026-07-19 from https://api.ai-analytics.org/clinical/NCT00675051. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*